Achillion Pharma (ACHN) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents	40.36M
Marketable securities
Accounts and other receivables	385K
Prepaid expenses and other current assets	2.75M
Total current assets	411.84M
Fixed assets, net	3.15M
Deferred financing costs
Restricted cash	152K
Total assets	415.19M
Accounts payable	5.45M
Accrued expenses	8.08M
Current portion of long-term debt	234K
Total current liabilities	13.76M
Long-term debt	55K
Deferred revenue
Total liabilities	13.98M
Commitments and contingencies	0
Common Stock, $.001 par value; 200,000 and 100,000, respectively, shares authorized: 69,719 and 58,376 shares issued and outstanding at June 30, 2011 and December 31, 2010, respectively	137K
Additional paid-in capital	913.75M
Accumulated deficit	-512.99M
Accumulated other comprehensive income	310K
Total stockholders' equity	401.21M
Total liabilities and stockholders' equity	415.19M

Entities mentioned with ACHN

View All Entities